PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Tributyl O-acetylcitrate

EC / List no: 201-067-0 CAS no: 77-90-7
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Follow-up
Decision date
09-pro-2022
Decision
Latest update
06-lip-2024
Additional information
This Decision has been upheld by the Board of Appeal in its decision in Case No.
A-003-2023.
More information View
DEv 2
Scope
Comprehensive
Status
Follow-up
Decision date
24-srp-2017
Decision
Latest update
26-stu-2022
Additional information
More information View
DEv 3
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-stu-2022
Additional information
ECHA has stopped the assessment after the registrant(s) submitted new information.
More information View
DEv 4
Scope
Comprehensive
Status
Follow-up
Decision date
08-pro-2017
Decision
Latest update
26-stu-2022
Additional information
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
France
Status
Concluded
Outcome
not ED
Hazard assessment outcome document
Remarks
Regarding the outcome of the ED assessment, refer to RMOA conclusion document. Reason for selecting the substance for hazard assessment development: substance known/suspected to be used as an alternative to a SVHC already on the Candidate List.
Concern
Endocrine disruption
Date of intention
12-stu-2014
Date of hazard assessment
15-lis-2016
Latest update
19-pro-2016
More information View
Regulatory risk management
Assessment of regulatory needs
ARN 1
Authority
France
Concern
Endocrine disruption
Status
Concluded
Follow-up
None
Foreseen regulatory need
Summary document
Group name
Remarks
Reason for selecting the substance for hazard assessment development: substance known/suspected to be used as an alternative to a SVHC already on the Candidate List.
Date of intention
12-stu-2014
Date of assessment
07-stu-2016
Latest update
24-stu-2021
More information View

List entry date: 12-lis-2018

Export search results to: